Home / ARHGEF10L Knockout Cell Lines

ARHGEF10L Knockout Cell Lines

Gene: ARHGEF10L

Official Full Name: Rho guanine nucleotide exchange factor 10 likeprovided by HGNC

Gene Summary: This gene belongs to the RhoGEF subfamily of RhoGTPases. Members of this subfamily are activated by specific guanine nucleotide exchange factors (GEFs) and are involved in signal transduction. The encoded protein shows cytosolic distribution. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2016]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO19707 ARHGEF10L Knockout cell line (HeLa) Human ARHGEF10L 1:3~1:6 Negative Online Inquiry
KO19708 ARHGEF10L Knockout cell line (HCT 116) Human ARHGEF10L 1:2~1:4 Negative Online Inquiry
KO19709 ARHGEF10L Knockout cell line (HEK293) Human ARHGEF10L 1:3~1:6 Negative Online Inquiry
KO19710 ARHGEF10L Knockout cell line (A549) Human ARHGEF10L 1:3~1:4 Negative Online Inquiry

Background

ARHGEF10L Gene Knockout Cell Lines are specialized cell lines engineered to lack the expression of the ARHGEF10L gene, which encodes a guanine nucleotide exchange factor involved in intracellular signaling pathways critical for cytoskeletal organization and cellular migration. These knockout models serve as invaluable tools for investigating the role of ARHGEF10L in various biological processes and disease states. By utilizing these cell lines, researchers can study the effects of ARHGEF10L deficiency on cellular behavior, providing insights into conditions such as cancer metastasis, neurodegeneration, and cardiovascular diseases.

The key function of ARHGEF10L is its regulation of Rho GTPases, which are pivotal in controlling actin dynamics, cell shape, and movement. The knockout of this gene effectively removes the regulatory influence on these pathways, allowing for the dissection of cellular mechanisms with precision. This can significantly enhance the understanding of how disruptions in these pathways can lead to pathological conditions, making it particularly relevant in both basic research and therapeutic development.

Scientifically, these knockout cell lines provide a robust platform for drug screening and validation, enabling the identification of potential therapeutics targeting the ARHGEF10L pathway. Moreover, they facilitate the exploration of compensatory mechanisms that may arise in the absence of the gene, thus offering a comprehensive view of cellular responses.

Compared to traditional cell line models, ARHGEF10L Gene Knockout Cell Lines offer unique advantages, such as specific pathway dissection and reduced off-target effects, which are often seen with pharmacological inhibitors. Their genetic validation ensures that any observed phenotypic changes are directly attributable to ARHGEF10L modulation, enhancing the reliability of experimental outcomes.

For researchers and clinicians involved in cellular biology, molecular mechanisms, and therapeutic interventions, ARHGEF10L Gene Knockout Cell Lines represent a transformative resource. These models empower scientists to uncover novel insights into disease mechanisms, ultimately aiding the development of innovative therapeutic strategies. Our company, with its robust expertise in producing high-quality biological products, is committed to advancing research methodologies and supporting the scientific community with unparalleled resources.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.